However, the prognostic impact of this molecule in tumor tissue is still controversial in various cancers, such as NSCLC and head and neck squamous cell carcinoma, because of the high discrepancies between PD-L1 expression and treatment outcomes [54,55]. Here, CD274 is linked to non-small cell lung carcinoma.